featured
Efficacy and Safety of Dapagliflozin in Children and Young Adults With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
Lancet Diabetes Endocrinol 2022 Apr 01;[EPub Ahead of Print], WV Tamborlane, LM Laffel, N Shehadeh, E Isganaitis, M Van Name, J Ratnayake, C Karlsson, E NorjavaaraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.